中国正式成为世卫组织国际癌症研究机构(IARC)第27个成员国

2021-05-24 JACKZHAO MedSci原创

2021年5月17-18日,世界卫生组织国际癌症研究机构(WHO/IARC)第63届理事会在线上举行。经各成员国一致通过,中国成为IARC第27个成员国,这也标志着中国正式步入肿瘤防治领域的国际大舞台

2021年5月17-18日,世界卫生组织国际癌症研究机构(WHO/IARC)第63届理事会称,经各成员国一致通过,中国成为IARC第27个成员国,这也标志着中国正式步入肿瘤防治领域的国际大舞台。

国家癌症中心主任赫捷院士在IARC理事会上代表中国发言,他表示中国高度重视与国际社会开展癌症防控领域的交流合作,中国加入IARC必将进一步促进双方合作,推动中国专家和专业技术机构与国际同道的务实交流合作,必将有利于全球癌症防控和科研合作。国家癌症研究中心主任赫捷院士当选IARC科学理事会成员。

国际癌症研究机构是世卫组织的专门癌症研究机构,于1965年5月根据世界卫生大会的一项决议成立。该机构是一个多学科研究所,具有流行病学、实验室科学、生物统计学和生物信息学方面的专门知识。I旨在通过多学科交流促进全球的肿瘤研究和预防的合作。其主要工作内容有:确定肿瘤的病因和预防策略、提供癌症信息的全球参考、建立全球的生物样本库、开展教育和培训、为全球肿瘤防控政策的制定提供循证医学证据。

 

在此之前,IARC的成员国有26个,遍布全球五大洲,它们是:澳大利亚、奥地利、比利时、巴西、加拿大、丹麦、芬兰、法国、德国、印度、伊朗、爱尔兰、意大利、日本、摩洛哥、荷兰、挪威、卡塔尔、韩国、俄罗斯、西班牙、瑞典、瑞士、土耳其、英国、美国。

中国与IARC的科研合作源于上世纪八十年代。

数十年间,中国学者与IARC的专家们开展了方方面面的合作:IARC奖学金项目、Summer School项目、肿瘤登记项目、人乳头瘤病毒感染和宫颈癌防治项目、癌症筛查指南项目等。

2013年,国家癌症中心与IARC签署首个合作谅解备忘录。

2017年,国家癌症中心与IARC续签合作谅解备忘录,进一步加强在肿瘤登记、筛查和早诊早治、肿瘤研究、人员培训等各方面的合作。同时,IARC正式授予国家癌症中心“IARC中国合作中心”的牌子。

国家癌症中心下属全国肿瘤登记中心也与IARC的癌症监测部签订了《合作研究和学术交流协定书》,共促我国肿瘤登记及肿瘤防控工作的全面发展。

 

参考资料:

https://www.iarc.who.int/news-events/china-joins-the-international-agency-for-research-on-cancer/

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2071446, encodeId=ded120e14465f, content=<a href='/topic/show?id=78a192865a' target=_blank style='color:#2F92EE;'>#IARC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9286, encryptionId=78a192865a, topicName=IARC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c25323, createdName=jambiya, createdTime=Mon Jun 07 23:18:12 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1935395, encodeId=7f761935395e5, content=<a href='/topic/show?id=44dce341015' target=_blank style='color:#2F92EE;'>#研究机构#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73410, encryptionId=44dce341015, topicName=研究机构)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIibticIBly5jCSic5ZElW4He3rO4DMpUHUFaFX57OicNMnzckWaicBNeStwugWHFCuOdicoakApM4HGmtw/132, createdBy=f8672500006, createdName=ms6390871039024434, createdTime=Mon Nov 22 10:18:12 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971818, encodeId=dccb9e18186f, content=威武我国, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c8e5452710, createdName=ms4000001114161496, createdTime=Tue Jun 08 13:02:49 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300939, encodeId=5948130093912, content=<a href='/topic/show?id=d6f720e61ab' target=_blank style='color:#2F92EE;'>#世卫组织#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20761, encryptionId=d6f720e61ab, topicName=世卫组织)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Wed May 26 04:18:12 CST 2021, time=2021-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1514206, encodeId=956e1514206c5, content=<a href='/topic/show?id=448ee1455a3' target=_blank style='color:#2F92EE;'>#癌症研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71455, encryptionId=448ee1455a3, topicName=癌症研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42c410636799, createdName=小华子, createdTime=Wed May 26 04:18:12 CST 2021, time=2021-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968234, encodeId=93419682340b, content=威武我国, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f18e5463974, createdName=ms7000000414344418, createdTime=Mon May 24 21:02:38 CST 2021, time=2021-05-24, status=1, ipAttribution=)]
    2021-06-07 jambiya
  2. [GetPortalCommentsPageByObjectIdResponse(id=2071446, encodeId=ded120e14465f, content=<a href='/topic/show?id=78a192865a' target=_blank style='color:#2F92EE;'>#IARC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9286, encryptionId=78a192865a, topicName=IARC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c25323, createdName=jambiya, createdTime=Mon Jun 07 23:18:12 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1935395, encodeId=7f761935395e5, content=<a href='/topic/show?id=44dce341015' target=_blank style='color:#2F92EE;'>#研究机构#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73410, encryptionId=44dce341015, topicName=研究机构)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIibticIBly5jCSic5ZElW4He3rO4DMpUHUFaFX57OicNMnzckWaicBNeStwugWHFCuOdicoakApM4HGmtw/132, createdBy=f8672500006, createdName=ms6390871039024434, createdTime=Mon Nov 22 10:18:12 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971818, encodeId=dccb9e18186f, content=威武我国, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c8e5452710, createdName=ms4000001114161496, createdTime=Tue Jun 08 13:02:49 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300939, encodeId=5948130093912, content=<a href='/topic/show?id=d6f720e61ab' target=_blank style='color:#2F92EE;'>#世卫组织#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20761, encryptionId=d6f720e61ab, topicName=世卫组织)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Wed May 26 04:18:12 CST 2021, time=2021-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1514206, encodeId=956e1514206c5, content=<a href='/topic/show?id=448ee1455a3' target=_blank style='color:#2F92EE;'>#癌症研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71455, encryptionId=448ee1455a3, topicName=癌症研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42c410636799, createdName=小华子, createdTime=Wed May 26 04:18:12 CST 2021, time=2021-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968234, encodeId=93419682340b, content=威武我国, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f18e5463974, createdName=ms7000000414344418, createdTime=Mon May 24 21:02:38 CST 2021, time=2021-05-24, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2071446, encodeId=ded120e14465f, content=<a href='/topic/show?id=78a192865a' target=_blank style='color:#2F92EE;'>#IARC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9286, encryptionId=78a192865a, topicName=IARC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c25323, createdName=jambiya, createdTime=Mon Jun 07 23:18:12 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1935395, encodeId=7f761935395e5, content=<a href='/topic/show?id=44dce341015' target=_blank style='color:#2F92EE;'>#研究机构#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73410, encryptionId=44dce341015, topicName=研究机构)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIibticIBly5jCSic5ZElW4He3rO4DMpUHUFaFX57OicNMnzckWaicBNeStwugWHFCuOdicoakApM4HGmtw/132, createdBy=f8672500006, createdName=ms6390871039024434, createdTime=Mon Nov 22 10:18:12 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971818, encodeId=dccb9e18186f, content=威武我国, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c8e5452710, createdName=ms4000001114161496, createdTime=Tue Jun 08 13:02:49 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300939, encodeId=5948130093912, content=<a href='/topic/show?id=d6f720e61ab' target=_blank style='color:#2F92EE;'>#世卫组织#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20761, encryptionId=d6f720e61ab, topicName=世卫组织)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Wed May 26 04:18:12 CST 2021, time=2021-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1514206, encodeId=956e1514206c5, content=<a href='/topic/show?id=448ee1455a3' target=_blank style='color:#2F92EE;'>#癌症研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71455, encryptionId=448ee1455a3, topicName=癌症研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42c410636799, createdName=小华子, createdTime=Wed May 26 04:18:12 CST 2021, time=2021-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968234, encodeId=93419682340b, content=威武我国, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f18e5463974, createdName=ms7000000414344418, createdTime=Mon May 24 21:02:38 CST 2021, time=2021-05-24, status=1, ipAttribution=)]
    2021-06-08 ms4000001114161496

    威武我国

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2071446, encodeId=ded120e14465f, content=<a href='/topic/show?id=78a192865a' target=_blank style='color:#2F92EE;'>#IARC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9286, encryptionId=78a192865a, topicName=IARC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c25323, createdName=jambiya, createdTime=Mon Jun 07 23:18:12 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1935395, encodeId=7f761935395e5, content=<a href='/topic/show?id=44dce341015' target=_blank style='color:#2F92EE;'>#研究机构#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73410, encryptionId=44dce341015, topicName=研究机构)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIibticIBly5jCSic5ZElW4He3rO4DMpUHUFaFX57OicNMnzckWaicBNeStwugWHFCuOdicoakApM4HGmtw/132, createdBy=f8672500006, createdName=ms6390871039024434, createdTime=Mon Nov 22 10:18:12 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971818, encodeId=dccb9e18186f, content=威武我国, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c8e5452710, createdName=ms4000001114161496, createdTime=Tue Jun 08 13:02:49 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300939, encodeId=5948130093912, content=<a href='/topic/show?id=d6f720e61ab' target=_blank style='color:#2F92EE;'>#世卫组织#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20761, encryptionId=d6f720e61ab, topicName=世卫组织)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Wed May 26 04:18:12 CST 2021, time=2021-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1514206, encodeId=956e1514206c5, content=<a href='/topic/show?id=448ee1455a3' target=_blank style='color:#2F92EE;'>#癌症研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71455, encryptionId=448ee1455a3, topicName=癌症研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42c410636799, createdName=小华子, createdTime=Wed May 26 04:18:12 CST 2021, time=2021-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968234, encodeId=93419682340b, content=威武我国, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f18e5463974, createdName=ms7000000414344418, createdTime=Mon May 24 21:02:38 CST 2021, time=2021-05-24, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2071446, encodeId=ded120e14465f, content=<a href='/topic/show?id=78a192865a' target=_blank style='color:#2F92EE;'>#IARC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9286, encryptionId=78a192865a, topicName=IARC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c25323, createdName=jambiya, createdTime=Mon Jun 07 23:18:12 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1935395, encodeId=7f761935395e5, content=<a href='/topic/show?id=44dce341015' target=_blank style='color:#2F92EE;'>#研究机构#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73410, encryptionId=44dce341015, topicName=研究机构)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIibticIBly5jCSic5ZElW4He3rO4DMpUHUFaFX57OicNMnzckWaicBNeStwugWHFCuOdicoakApM4HGmtw/132, createdBy=f8672500006, createdName=ms6390871039024434, createdTime=Mon Nov 22 10:18:12 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971818, encodeId=dccb9e18186f, content=威武我国, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c8e5452710, createdName=ms4000001114161496, createdTime=Tue Jun 08 13:02:49 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300939, encodeId=5948130093912, content=<a href='/topic/show?id=d6f720e61ab' target=_blank style='color:#2F92EE;'>#世卫组织#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20761, encryptionId=d6f720e61ab, topicName=世卫组织)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Wed May 26 04:18:12 CST 2021, time=2021-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1514206, encodeId=956e1514206c5, content=<a href='/topic/show?id=448ee1455a3' target=_blank style='color:#2F92EE;'>#癌症研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71455, encryptionId=448ee1455a3, topicName=癌症研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42c410636799, createdName=小华子, createdTime=Wed May 26 04:18:12 CST 2021, time=2021-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968234, encodeId=93419682340b, content=威武我国, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f18e5463974, createdName=ms7000000414344418, createdTime=Mon May 24 21:02:38 CST 2021, time=2021-05-24, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=2071446, encodeId=ded120e14465f, content=<a href='/topic/show?id=78a192865a' target=_blank style='color:#2F92EE;'>#IARC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9286, encryptionId=78a192865a, topicName=IARC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c25323, createdName=jambiya, createdTime=Mon Jun 07 23:18:12 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1935395, encodeId=7f761935395e5, content=<a href='/topic/show?id=44dce341015' target=_blank style='color:#2F92EE;'>#研究机构#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73410, encryptionId=44dce341015, topicName=研究机构)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIibticIBly5jCSic5ZElW4He3rO4DMpUHUFaFX57OicNMnzckWaicBNeStwugWHFCuOdicoakApM4HGmtw/132, createdBy=f8672500006, createdName=ms6390871039024434, createdTime=Mon Nov 22 10:18:12 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971818, encodeId=dccb9e18186f, content=威武我国, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c8e5452710, createdName=ms4000001114161496, createdTime=Tue Jun 08 13:02:49 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300939, encodeId=5948130093912, content=<a href='/topic/show?id=d6f720e61ab' target=_blank style='color:#2F92EE;'>#世卫组织#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20761, encryptionId=d6f720e61ab, topicName=世卫组织)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Wed May 26 04:18:12 CST 2021, time=2021-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1514206, encodeId=956e1514206c5, content=<a href='/topic/show?id=448ee1455a3' target=_blank style='color:#2F92EE;'>#癌症研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71455, encryptionId=448ee1455a3, topicName=癌症研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42c410636799, createdName=小华子, createdTime=Wed May 26 04:18:12 CST 2021, time=2021-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968234, encodeId=93419682340b, content=威武我国, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f18e5463974, createdName=ms7000000414344418, createdTime=Mon May 24 21:02:38 CST 2021, time=2021-05-24, status=1, ipAttribution=)]
    2021-05-24 ms7000000414344418

    威武我国

    0

相关资讯

Lancet:7种化合物被IARC列入“对人类可能致癌”名单

2017年6月,在法国里昂召开的IARC(国际癌症研究机构)会议中,来自9个国家的21名科学家最终确定了他们对7种化合物致癌性的关键性评价。这7种化合物包括三聚氰胺(melamine),1-叔丁氧基丙-2-醇(1-tertbutoxypropan-2-ol),β-月桂烯(β-myrcene),糠醇(furfurylalcohol),吡啶(pyridine),四氢呋喃(tetrahydrofuran

NEJM:乳腺癌筛查指南更新——IARC观点

乳腺癌筛查的目的是通过对无症状女性进行早期检测,降低这种癌症的死亡率,以及与疾病晚期相关的发病率。使筛查的作用达到最大化的关键是早期获取有效的诊断和治疗。而筛查的综合质量是保持筛查利弊平衡的重中之重。  6月3日《新英格兰医学杂志》(New Engl J Med)在线发布国际癌症研究机构(IARC)乳腺癌筛查指南。IARC此次对其2002发布的乳腺癌筛查手册的更新主要基于以下几个方面原因。1.晚期

自如甲醛又超标!IARC已将甲醛列为一类致癌物

刘雅通过自如租下了房子。7月体检,检查出其体内的白细胞数量只有2.23,相当于正常人的60%,就像刚做过化疗的病人一样。房屋检测报告显示,甲醛、TVOC均不合格!